cidofovir

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:cytomegalovirus
gptkbp:activities inhibits viral DNA polymerase
gptkbp:appointed_by intravenous injection
gptkbp:approves gptkb:1996
gptkb:FDA
gptkbp:availability prescription only
gptkbp:brand Vistide
gptkbp:class nucleotide analog
gptkbp:clinical_trial in immunocompromised patients
ongoing studies for other viral infections
gptkbp:composed_of chemical synthesis process
gptkbp:contraindication renal impairment
hypersensitivity to cidofovir
gptkbp:developed_by gptkb:Gilead_Sciences
gptkbp:discontinued in patients with severe renal impairment
gptkbp:dosage_form once a week
gptkbp:duration depends on clinical response
gptkbp:formulation sterile solution
https://www.w3.org/2000/01/rdf-schema#label cidofovir
gptkbp:indication AIDS-related CMV retinitis
gptkbp:ingredients C12 H15 Cl N2 O4 P
gptkbp:interacts_with with other nephrotoxic drugs
with probenecid
gptkbp:invention held by Gilead Sciences
gptkbp:is_monitored_by renal function
gptkbp:is_used_for treating cytomegalovirus (CMV) retinitis
gptkbp:manager intravenous
gptkbp:marketed_as gptkb:Europe
gptkb:United_States
gptkbp:pharmacokinetics inhibits viral replication
long half-life
gptkbp:research effective against other herpesviruses
investigated for HPV treatment
investigated for adenovirus infections
potential use in Ebola virus treatment
potential use in other viral diseases
potential use in smallpox treatment
studied for BK virus nephropathy
studied for Zika virus treatment
gptkbp:research_areas viral infections
gptkbp:rounds renal excretion
gptkbp:safety_features requires monitoring
gptkbp:side_effect gptkb:fandom
headache
nausea
diarrhea
thrombocytopenia
nephrotoxicity
neutropenia
ocular inflammation
gptkbp:storage room temperature
gptkbp:treatment with other antiviral agents
gptkbp:type_of 113852-37-2